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Background
Mutations in the CHD7 gene cause CHARGE, a develop-
mental syndrome which affect most organs. In addition,
CHD7 mutations also cause puberty and reproductive
organ formation disorders such as Idiopathic Hypogona-
dotropic Hypogonadism and Kallmann Syndrome. Genetic
studies in model organisms have further established
CHD7 as a central regulator of vertebrate development.
To understand how the CHD7 proteins achieve its func-
tion and how mutation of CHD7 leads to developmental
disorders, it is critical to characterize WT and mutant
CHD7 proteins biochemically. However to date, CHD7
has not been characterized for activity, as it is extremely
large and has resisted purification.
Materials and methods
We used the baculovirus system and a dual-tag strategy to
purify intact recombinant WT and mutant CHD7 pro-
teins. We subjected these polypeptides to nucleosome
remodeling and ATPase assays to characterize the CHD7
basic properties, perform a structure-function analysis of
CHD7 and examine point mutants reported in human
patients.
Results
We show that CHD7 is an ATP-dependent nucleosome
remodeling factor and that it has characteristics distinct
from SWI/ SNF- and ISWI-type remodelers. Further inves-
tigations show that CHD7 patient mutations have conse-
quences that range from subtle to complete inactivation of
remodeling activity, raising the possibility that even partial
impairment of remodeling function has a significant impact
on human biology. In addition, we find that patient muta-
tions leading to protein truncations upstream of amino
acid 1899 of CHD7 are likely to cause a hypomorphic phe-
notype for remodeling.
Conclusions
We propose that nucleosome remodeling is a key function
for CHD7 during developmental processes and provide a
molecular basis for predicting the impact of disease muta-
tions on that function.
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